Multimodality approach to treat calciphylaxis in end-stage kidney disease patients

References

• Zhou Y, Chen Y, Yin G, et al. Calciphylaxis and its co-occurrence with connective tissue diseases. Int Wound J. 2023;20(4):1–10. doi: 10.1111/iwj.13972.
   Web of Science ®Google Scholar
• Gallo Marin B, Aghagoli G, Hu SL, et al. Calciphylaxis and kidney disease: a review. Am J Kidney Dis. 2023;81(2):232–239. doi: 10.1053/j.ajkd.2022.06.011.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Kroshinsky D, Nazarian RM, et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66(1):133–146. doi: 10.1053/j.ajkd.2015.01.034.
   PubMed Web of Science ®Google Scholar
• Kaur R, Singh R. Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications. Life Sci. 2022;311(Pt B):121148. doi: 10.1016/j.lfs.2022.121148.
   PubMedGoogle Scholar
• Brandenburg VM, Kramann R, Specht P, et al. Calciphylaxis in CKD and beyond. Nephrol Dial Transplant. 2012;27(4):1314–1318. doi: 10.1093/ndt/gfs015.
   PubMed Web of Science ®Google Scholar
• Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int. 2002;61(6):2210–2217. doi: 10.1046/j.1523-1755.2002.00375.x.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Kramann R, Rothe H, et al. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant. 2017;32(1):126–132. doi: 10.1093/ndt/gfv438.
   PubMed Web of Science ®Google Scholar
• Nigwekar SU, Zhao S, Wenger J, et al. A nationally representative study of calcific uremic arteriolopathy risk factors. J Am Soc Nephrol. 2016;27(11):3421–3429. doi: 10.1681/ASN.2015091065.
   PubMed Web of Science ®Google Scholar
• Chang JJ. Calciphylaxis: diagnosis, pathogenesis, and treatment. Adv Skin Wound Care. 2019;32(5):205–215. doi: 10.1097/01.ASW.0000554443.14002.13.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Cozzolino M, Ketteler M. Calciphylaxis: a still unmet challenge. J Nephrol. 2011;24(2):142–148. doi: 10.5301/jn.2011.6366.
   PubMed Web of Science ®Google Scholar
• Toussaint ND, Lau KK, Strauss BJ, et al. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant. 2008;23(2):586–593. doi: 10.1093/ndt/gfm660.
   PubMed Web of Science ®Google Scholar
• Rick J, Strowd L, Pasieka HB, et al. Calciphylaxis: part I. Diagnosis and pathology. J Am Acad Dermatol. 2022;86(5):973–982. doi: 10.1016/j.jaad.2021.10.064.
   PubMed Web of Science ®Google Scholar
• Jiao Y, Sun L, Xie X, et al. Clinical features and outcomes of calciphylaxis in chinese patients with chronic kidney disease. Nephrology (Carlton). 2023;28(6):305–314. doi: 10.1111/nep.14156.
   PubMed Web of Science ®Google Scholar
• Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol. 2007;56(4):569–579. doi: 10.1016/j.jaad.2006.08.065.
   PubMed Web of Science ®Google Scholar
• Xia J, Tan AJ, Biglione B, et al. Nephrogenic calciphylaxis arising after bariatric surgery: a case series. Am J Nephrol. 2023. Online ahead of print. doi: 10.1159/000531784.
   Web of Science ®Google Scholar
• Farah M, Crawford RI, Levin A, et al. Calciphylaxis in the current era: emerging ‘ironic’ features? Nephrol Dial Transplant. 2011;26(1):191–195. doi: 10.1093/ndt/gfq407.
   PubMed Web of Science ®Google Scholar
• Jean G, Terrat JC, Vanel T, et al. [Calciphylaxis in dialysis patients: to recognize and treat it as soon as possible]. Nephrol Ther. 2010;6(6):499–504. doi: 10.1016/j.nephro.2010.04.003.
   PubMed Web of Science ®Google Scholar
• Wang HY, Yu CC, Huang CC. Successful treatment of severe calciphylaxis in a hemodialysis patient using low-calcium dialysate and medical parathyroidectomy: case report and literature review. Ren Fail. 2004;26(1):77–82. doi: 10.1081/jdi-120028559.
   PubMed Web of Science ®Google Scholar
• Smith R, Bulteel N, Gupta AA. S. Successful treatment of severe calciphylaxis in a renal transplant patient with previous total parathyroidectomy. J R Coll Physicians Edinb. 2023;
   Web of Science ®Google Scholar
• Sinha S, Gould LJ, Nigwekar SU, et al. The CALCIPHYX study: a randomized, double-blind, placebo-controlled, phase 3 clinical trial of SNF472 for the treatment of calciphylaxis. Clin Kidney J. 2022;15(1):136–144. doi: 10.1093/ckj/sfab117.
   PubMed Web of Science ®Google Scholar
• Perelló J, Ferrer MD, del Mar Pérez M, et al. Mechanism of action of SNF472, a novel calcification inhibitor to treat vascular calcification and calciphylaxis. Br J Pharmacol. 2020;177(19):4400–4415. doi: 10.1111/bph.15163.
   PubMed Web of Science ®Google Scholar
• Bian A, Ye X, Wang J, et al. Therapeutic effects and mechanism of human amnion-derived mesenchymal stem cells on hypercoagulability in a uremic calciphylaxis patient. Ren Fail. 2023;45(1):2218483. doi: 10.1080/0886022X.2023.2218483.
   PubMed Web of Science ®Google Scholar
• Qin L, Zhang J, Xiao Y, et al. A novel long-term intravenous combined with local treatment with human amnion-derived mesenchymal stem cells for a multidisciplinary rescued uremic calciphylaxis patient and the underlying mechanism. J Mol Cell Biol. 2022;14(2):mjac010. doi: 10.1093/jmcb/mjac010.
   PubMed Web of Science ®Google Scholar
• Wang NN, Qin LJ, Liu K[, et al. Multidisciplinary regenerative treatment and mechanisms for rescuing a severe calciphylaxis patient with human amnion-derived mesenchymal stem cells. ]. Zhonghua Yi Xue Za Zhi. 2022;102(28):2217–2221.
   PubMedGoogle Scholar
• Kelly E, O’Hagan J. Geographic clustering of economic activity: the case of prominent Western visual artists. J Cult Econ. 2007;31:109–128. doi: 10.1007/s10824-007-9035-x.
   Google Scholar
• Malbos S, Urena-Torres P, Bardin T, et al. Sodium thiosulfate is effective in calcific uremic arteriolopathy complicating chronic hemodialysis. Joint Bone Spine. 2016;83(1):89–92. doi: 10.1016/j.jbspin.2015.03.007.
   PubMed Web of Science ®Google Scholar
• Hayden MR, Tyagi SC, Kolb L, et al. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Cardiovasc Diabetol. 2005;4(1):4. doi: 10.1186/1475-2840-4-4.
   PubMedGoogle Scholar
• Araya CE, Fennell RS, Neiberger RE, et al. Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults. Clin J Am Soc Nephrol. 2006;1(6):1161–1166. doi: 10.2215/CJN.01520506.
   PubMed Web of Science ®Google Scholar
• Di J, Liu Y, Wang D, et al. A case of early calciphylaxis diagnosed by bone scan. Case Rep Med. 2020;2020:9526836.
   PubMed Web of Science ®Google Scholar
• Paul S, Rabito CA, Vedak P, et al. The role of bone scintigraphy in the diagnosis of calciphylaxis. JAMA Dermatol. 2017;153(1):101–103. doi: 10.1001/jamadermatol.2015.4591.
   PubMed Web of Science ®Google Scholar
• Han MM, Pang J, Shinkai K, et al. Calciphylaxis and bone scintigraphy: case report with histological confirmation and review of the literature. Ann Nucl Med. 2007;21(4):235–238. doi: 10.1007/s12149-007-0013-3.
   PubMed Web of Science ®Google Scholar
• Ghosh T, Winchester DS, Davis MDP, et al. Early clinical presentations and progression of calciphylaxis. Int J Dermatol. 2017;56(8):856–861. doi: 10.1111/ijd.13622.
   PubMed Web of Science ®Google Scholar
• Bliss DE. Calciphylaxis: what nurses need to know. Nephrol Nurs J. 2002;29(5):433–438. 443-434; quiz 445–436.
   PubMedGoogle Scholar
• Khanna U, Dominguez A, Keller J, et al. Update on calciphylaxis etiopathogenesis, diagnosis, and management. Cutis. 2018;102(6):395–400.
   PubMed Web of Science ®Google Scholar
• Zoi V, Bacharaki D, Sardeli A, et al. Calciphylaxis: a long road to cure with a multidisciplinary and multimodal approach. Case Rep Nephrol. 2022;2022:3818980. doi: 10.1155/2022/3818980.
   PubMedGoogle Scholar
• Yang X, Liu Y, Xie X, et al. Use of the optimized sodium thiosulfate regimen for the treatment of calciphylaxis in chinese patients. Ren Fail. 2022;44(1):914–922. doi: 10.1080/0886022X.2022.2081179.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Cozzolino M, Mazzaferro S. Calcific uremic arteriolopathy: a call for action. Semin Nephrol. 2014;34(6):641–647. doi: 10.1016/j.semnephrol.2014.09.007.
   PubMed Web of Science ®Google Scholar
• Schlieper G, Brandenburg V, Ketteler M, et al. Sodium thiosulfate in the treatment of calcific uremic arteriolopathy. Nat Rev Nephrol. 2009;5(9):539–543. doi: 10.1038/nrneph.2009.99.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Evenepoel P, Floege J, et al. Lack of evidence does not justify neglect: how can we address unmet medical needs in calciphylaxis? Nephrol Dial Transplant. 2016;31(8):1211–1219. doi: 10.1093/ndt/gfw025.
   PubMed Web of Science ®Google Scholar
• Al-Ani M, Parperis K. Warfarin-induced calciphylaxis. BMJ Case Rep. 2016;2016:bcr2015214142.
   PubMedGoogle Scholar
• Mac-Way F, Poulin A, Utescu MS, et al. The impact of warfarin on the rate of progression of aortic stiffness in hemodialysis patients: a longitudinal study. Nephrol Dial Transplant. 2014;29(11):2113–2120. doi: 10.1093/ndt/gfu224.
   PubMed Web of Science ®Google Scholar
• Santos PW, Wetmore JB. Sequential bone scintigraphy and the evolution of Warfarin-Mediated calcific uremic arteriolopathy. Case Rep Nephrol Dial. 2021;11(1):78–86. doi: 10.1159/000512611.
   PubMed Web of Science ®Google Scholar
• O’Neill WC, Hardcastle KI. The chemistry of thiosulfate and vascular calcification. Nephrol Dial Transplant. 2012;27(2):521–526. doi: 10.1093/ndt/gfr375.
   PubMed Web of Science ®Google Scholar
• Pasch A, Schaffner T, Huynh-Do U, et al. Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int. 2008;74(11):1444–1453. doi: 10.1038/ki.2008.455.
   PubMed Web of Science ®Google Scholar
• Chen NX, O’Neill K, Akl NK, et al. Adipocyte induced arterial calcification is prevented with sodium thiosulfate. Biochem Biophys Res Commun. 2014;449(1):151–156. doi: 10.1016/j.bbrc.2014.05.005.
   PubMed Web of Science ®Google Scholar
• O’Neill WC. Sodium thiosulfate: mythical treatment for a mysterious disease? Clin J Am Soc Nephrol. 2013;8(7):1068–1069.
   PubMed Web of Science ®Google Scholar
• Adirekkiat S, Sumethkul V, Ingsathit A, et al. Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant. 2010;25(6):1923–1929. doi: 10.1093/ndt/gfp755.
   PubMed Web of Science ®Google Scholar
• Generali JA, Cada DJ. Sodium thiosulfate: calciphylaxis. Hosp Pharm. 2015;50(11):975–977. doi: 10.1310/hpj5011-975.
   PubMedGoogle Scholar
• Kreymereman P. Sodium thiosulfate injection dissolves calcium hydroxylapatite particles: an animal study. Journal of the American Academy of Dermatology. 2018;79(3, Supplement 1):AB265.
   Web of Science ®Google Scholar
• Zhang MY, Dugbartey GJ, Juriasingani S, et al. Hydrogen sulfide metabolite, sodium thiosulfate: clinical applications and underlying molecular mechanisms. Int J Mol Sci. 2021;22(12):6452.
   PubMed Web of Science ®Google Scholar
• Hayden MR, Goldsmith DJ. Sodium thiosulfate: new hope for the treatment of calciphylaxis. Semin Dial. 2010;23(3):258–262. doi: 10.1111/j.1525-139X.2010.00738.x.
   PubMed Web of Science ®Google Scholar
• Wen W, Portales-Castillo I, Seethapathy R, et al. Intravenous sodium thiosulphate for calciphylaxis of chronic kidney disease: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(4):e2310068. doi: 10.1001/jamanetworkopen.2023.10068.
   PubMed Web of Science ®Google Scholar
• Peng T, Zhuo L, Wang Y, et al. Systematic review of ­sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients. Nephrology (Carlton). 2018;23(7):669–675. doi: 10.1111/nep.13081.
   PubMed Web of Science ®Google Scholar
• Teh YK, Renaud CJ. Clinical experience with intraperitoneal sodium thiosulphate for calciphylaxis in peritoneal dialysis: a case series. Perit Dial Int. 2023; doi: 10.1177/08968608231163669.
   PubMed Web of Science ®Google Scholar
• Brandenburg V, Adragao T, van Dam B, et al. Blueprint for a european calciphylaxis registry initiative: the european calciphylaxis network (EuCalNet). Clin Kidney J. 2015;8(5):567–571. doi: 10.1093/ckj/sfv056.
   PubMedGoogle Scholar
• Sood AR, Wazny LD, Raymond CB, et al. Sodium thiosulfate-based treatment in calcific uremic arteriolopathy: a consecutive case series. Clin Nephrol. 2011;75(1):8–15.
   PubMed Web of Science ®Google Scholar
• Noureddine L, Landis M, Patel N, et al. Efficacy of sodium thiosulfate for the treatment for calciphylaxis. Clin Nephrol. 2011;75(6):485–490. doi: 10.5414/cnp75485.
   PubMed Web of Science ®Google Scholar
• Zitt E, Konig M, Vychytil A, et al. Use of sodium thiosulphate in a multi-interventional setting for the treatment of calciphylaxis in dialysis patients. Nephrol Dial Transplant. 2013.
   Google Scholar
• Bourgeois P, Haes DP. Sodium thiosulfate as a treatment for calciphylaxis: a case series. J Dermatolog Treat. 2016;27(6):520–524.
   PubMed Web of Science ®Google Scholar
• Loidi Pascual L, Valcayo Penalba A, Oscoz Jaime S, et al. [Calciphylaxis. A review of 9 cases]. Med Clin (Barc). 2016;147(4):157–161. doi: 10.1016/j.medcli.2016.05.021.
   PubMed Web of Science ®Google Scholar
• Jang A, Mark Ho MH, Yan L. Characterization of risk factors for calciphylaxis in hemodialysis patients in the fraser health renal Program - A matched Case-Control retrospective review. J Pharm Pract. 2022;
   PubMed Web of Science ®Google Scholar
• Jovanovich A, Chonchol M. Calcific uremic arteriolopathy revisited. J Am Soc Nephrol. 2016;27(11):3233–3235. doi: 10.1681/ASN.2016040480.
   PubMed Web of Science ®Google Scholar
• Sun Y, Tian B, Sheng Z, et al. Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis. BMC Nephrol. 2020;21(1):316. doi: 10.1186/s12882-019-1639-9.
   PubMed Web of Science ®Google Scholar
• Xu J, Yang Y, Ma L, et al. Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials. Int Urol Nephrol. 2019;51(11):2027–2036. doi: 10.1007/s11255-019-02271-6.
   PubMed Web of Science ®Google Scholar
• Deen J, Schaider H. The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: a comprehensive review. Australas J Dermatol. 2019;60(3):e186–e194. doi: 10.1111/ajd.12992.
   PubMed Web of Science ®Google Scholar
• Raymond CB, Wazny LD. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis. Am J Health Syst Pharm. 2008;65(15):1419–1429. doi: 10.2146/ajhp070546.
   PubMed Web of Science ®Google Scholar
• Rishavy MA, Hallgren KW, Wilson L, et al. Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase. Blood. 2018;131(25):2826–2835. doi: 10.1182/blood-2017-09-804666.
   PubMed Web of Science ®Google Scholar
• Brandenburg VM, Schurgers LJ, Kaesler N, et al. Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact? Atherosclerosis. 2015;240(1):10–16. doi: 10.1016/j.atherosclerosis.2015.02.040.
   PubMed Web of Science ®Google Scholar
• Jean G, Bresson E, Terrat JC, et al. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2009;24(3):948–955. doi: 10.1093/ndt/gfn571.
   PubMed Web of Science ®Google Scholar
• Caluwe R, Pyfferoen L, De Boeck K, et al. The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J. 2016;9(2):273–279. doi: 10.1093/ckj/sfv146.
   PubMed Web of Science ®Google Scholar
• Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-Analysis of randomized trials. J Am Coll Cardiol. 2023;81(1):16–30. doi: 10.1016/j.jacc.2022.10.008.
   PubMed Web of Science ®Google Scholar
• Dufrost V, Wahl D, Zuily S. Direct oral anticoagulants in antiphospholipid syndrome: meta-analysis of randomized controlled trials. Autoimmun Rev. 2021;20(1):102711. doi: 10.1016/j.autrev.2020.102711.
   PubMed Web of Science ®Google Scholar
• Wu X, Cao S, Yu B, et al. Comparing the efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis. Blood Coagul Fibrinolysis. 2022;33(7):389–401. doi: 10.1097/MBC.0000000000001153.
   PubMed Web of Science ®Google Scholar
• Ruderman I, Toussaint ND, Hawley CM, et al. The Australian calciphylaxis registry: reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dial Transplant. 2021;36(4):649–656. doi: 10.1093/ndt/gfz256.
   PubMed Web of Science ®Google Scholar
• Boucek MM, Aurora P, Edwards LB, et al. Registry of the international society for heart and lung transplantation: tenth official pediatric heart transplantation report–2007. J Heart Lung Transplant. 2007;26(8):796–807. doi: 10.1016/j.healun.2007.06.006.
   PubMed Web of Science ®Google Scholar
• Stehlik J, Edwards LB, Rowe A, et al. ISHLT international registry for heart and lung transplantation - three decades of scientific contributions. Transplant Rev (Orlando). 2013;27(2):38–42. doi: 10.1016/j.trre.2013.01.005.
   PubMedGoogle Scholar
• International severe asthma registry: mission statement. Chest. 2020;157(4):805–814.
   PubMed Web of Science ®Google Scholar
• Rock G. International forum: the world apheresis association registry. Transfus Apher Sci. 2023;62(1):103630. doi: 10.1016/j.transci.2022.103630.
   PubMed Web of Science ®Google Scholar
• Ghadri JR, Cammann VL, Templin C. The international takotsubo registry: rationale, design, objectives, and first results. Heart Fail Clin. 2016;12(4):597–603. doi: 10.1016/j.hfc.2016.06.010.
   PubMed Web of Science ®Google Scholar
• Golper TA. Hemodiafiltration outcomes in special situations. Semin Dial. 2022;35(5):431–435. doi: 10.1111/sdi.13074.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Yang T, Li Y, et al. Effects of expanded hemodialysis with medium Cut-Off membranes on maintenance hemodialysis patients: a review. Membranes. 2022;12(3):253. doi: 10.3390/membranes12030253.
   PubMed Web of Science ®Google Scholar
• Valga F, Monzón T, Rincón M, et al. Synergy of sodium thiosulphate treatment and expanded hemodialysis in the management of calciphylaxis? A case report. Nefrologia (Engl Ed). 2022;42(3):354–356. doi: 10.1016/j.nefroe.2022.09.001.
   PubMed Web of Science ®Google Scholar